Pharmaceutical package
Latest Janssen Biotech, Inc. Patents:
- Use of small molecules to enhance MAFA expression in pancreatic endocrine cells
- Materials and methods for the manufacture of pluripotent stem cells
- Substituted aminopyridine compounds as EGFR inhibitors
- MATERIALS AND METHODS FOR MODULATING T CELL MEDIATED IMMUNITY
- DYNAMIC MONOSACCHARIDE CONTROL PROCESSES
The broken line portion in the drawings illustrates portions of the pharmaceutical package that form no part of the claimed design.
Claims
The ornamental design for a pharmaceutical package, as shown and described.
D249617 | September 26, 1978 | Bozicnik |
7441655 | October 28, 2008 | Hoftman |
D698644 | February 4, 2014 | Teopas |
D740650 | October 13, 2015 | Waldron |
D817172 | May 8, 2018 | Jones |
D895145 | September 1, 2020 | Smith |
D906815 | January 5, 2021 | Yu |
D918032 | May 4, 2021 | Smith |
D934069 | October 26, 2021 | Cook |
20180085515 | March 29, 2018 | Mide |
20190092547 | March 28, 2019 | Sadowski |
1386753 | May 2010 | JP |
D103295 | March 2005 | TW |
D103296 | March 2005 | TW |
Type: Grant
Filed: Sep 18, 2020
Date of Patent: Apr 19, 2022
Assignee: Janssen Biotech, Inc. (Horsham, PA)
Inventors: Cedric Gysel (Zurich/Canton Zurich), Michael Cannamela (Atlantic Highlands, NJ), Roland Schultz (Stein), Peter Braun (Hallau)
Primary Examiner: Lauren R Calve
Application Number: 29/751,225